烤水平和造周期对消耗咖啡粉中的生物活性化合物的影响
Nur Maiyah1, Soraya Kerdpiboon1, William L Kerr2
1School of Food Industry, King Mongkut's Institute of Technology Ladkrabang, Bangkok 10520, Thailand.
Food chemistry: X
|February 27, 2026
概括
消耗的咖啡 (SCG) 是生物活性化合物的宝贵来源. 造周期显著影响复合物回收,Robusta SCGs显示出可持续食品应用的更高潜力.
科学领域:
- 食品科学 食品科学 食品科学
- 可持续化学 可持续化学
- 生物技术是生物技术.
背景情况:
- 消耗的咖啡 (SCG) 是咖啡造的副产品.
- SCGs含有有价值的生物活性化合物,如,黄,咖啡因和酸.
- 可持续利用SCG对于减少废物和资源回收至关重要.
研究的目的:
- 调查烤水平和连续造周期对从阿拉比卡和罗布斯塔SCG中恢复生物活性化合物的影响.
- 确定造历史对SCG化学特征的影响.
- 评估SCG在可持续功能性食品应用中的潜力.
主要方法:
- 咖啡豆 (阿拉伯咖啡和罗布斯塔咖啡) 在不同水平 (轻,中,深) 烤.
- SCG 经历了三次连续的水热造周期.
- 使用70%的乙醇提取总含量 (TPC),总黄含量 (TFC),咖啡因和酸 (CGA).
- 主要成分分析 (PCA) 用于分析化学配置文件.
主要成果:
- 第一个造周期从SCG中去除了大部分水溶性生物活性化合物.
- 随后的造周期导致较小的组成变化,表明化合物持久性.
- 与阿拉比卡相比,罗布斯塔SCG表现出更高的TPC和抗氧化活性.
- 咖啡因含量随造周期而减少,而酸 (CGA) 则对热量敏感.
- 造影响了最初的生物活性特征,但造后的影响减少了.
结论:
- 造历史是影响SCG化学成分的主要因素.
- 即使经过多个造周期,SCG也保留了重要的生物活性化合物.
- 这些发现支持将SCG用于功能性食品应用的价值化,考虑到造参数.
- 通过明智的处理策略,可以实现SCG的可持续再利用.
更多相关视频
08:43PTR-ToF-MS Coupled with an Automated Sampling System and Tailored Data Analysis for Food Studies: Bioprocess Monitoring, Screening and Nose-space Analysis
Published on: May 11, 2017
13.1K
10:13Using Capillary Electrophoresis to Quantify Organic Acids from Plant Tissue: A Test Case Examining Coffea arabica Seeds
Published on: November 12, 2016
10.3K
相关概念视频
Bioavailability: Influencing Factors
482
Bioavailability refers to the extent and rate at which a drug reaches systemic circulation in its active form. Extent refers to the amount of the drug that makes it into circulation, while rate is the speed at which it enters circulation. It is influenced by several factors critical for optimizing drug formulations, dosing regimens, and therapeutic outcomes.Physicochemical properties of drugs and formulationsThe solubility, stability, and dissolution rate of a drug significantly impact its...
482
Factors Influencing Bioavailability: First-Pass Elimination
8.3K
When a drug is taken orally, it undergoes a journey starting from the gastrointestinal (GI) tract, passing through the portal vein, reaching the liver, and finally entering the systemic circulation. This process involves the absorption of the drug across the GI tract. The liver is the primary site for metabolizing the drug, with some metabolism also occurring in the gut wall. This journey significantly reduces the quantity of the drug that reaches the systemic circulation, a phenomenon known as...
8.3K
